Recent progress in protein profiling of clinical tissues for next-generation molecular diagnostics

References

• Akbani R, Ng PK, Werner HM, et al. A pan-cancer proteomic perspective on the cancer genome atlas. Nat Commun 2014;5:3887
   PubMed Web of Science ®Google Scholar
• Becker KF, Schott C, Becker I, et al. Guided protein extraction from formalin-fixed tissues for quantitative multiplex analysis avoids detrimental effects of histological stains. Proteomics Clin Appl 2008;2:737-43
   PubMed Web of Science ®Google Scholar
• Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001
   PubMed Web of Science ®Google Scholar
• Espina V, Heiby M, Pierobon M, et al. Laser capture microdissection technology. Expert Rev Mol Diagn 2007;7:647-57
   PubMed Web of Science ®Google Scholar
• Kolble K. The LEICA microdissection system: design and applications. J Mol Med (Berl) 2000;78:B24-5
   PubMed Web of Science ®Google Scholar
• Becker I, Becker KF, Rohrl MH, et al. Single-cell mutation analysis of tumors from stained histologic slides. Lab Invest 1996;75:801-7
   PubMed Web of Science ®Google Scholar
• Pierobon M, Wulfkuhle J, Liotta L, et al. Application of molecular technologies for phosphoproteomic analysis of clinical samples. Oncogene 2015;34:805-14
   PubMed Web of Science ®Google Scholar
• Brennan DJ, O’Connor DP, Rexhepaj E, et al. Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat Rev Cancer 2010;10:605-17
   PubMed Web of Science ®Google Scholar
• Paweletz CP, Charboneau L, Bichsel VE, et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001;20:1981-9
   PubMed Web of Science ®Google Scholar
• Domon B, Aebersold R. Options and considerations when selecting a quantitative proteomics strategy. Nat Biotechnol 2010;28:710-21
   PubMed Web of Science ®Google Scholar
• Zhou W, Liotta LA, Petricoin EF. Cancer metabolism and mass spectrometry-based proteomics. Cancer Lett 2015;356:176-83
   PubMed Web of Science ®Google Scholar
• Alfaro JA, Sinha A, Kislinger T, et al. Onco-proteogenomics: cancer proteomics joins forces with genomics. Nat Methods 2014;11:1107-13
   PubMed Web of Science ®Google Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006;24:971-83
   PubMed Web of Science ®Google Scholar
• Amberger J, Bocchini CA, Scott AF, et al. McKusick’s online Mendelian inheritance in man (OMIM). Nucleic Acids Res 2009;37:D793-6
   Web of Science ®Google Scholar
• Lane L, Argoud-Puy G, Britan A, et al. neXtProt: a knowledge platform for human proteins. Nucleic Acids Res 2012;40:D76-83
   PubMed Web of Science ®Google Scholar
• Kim N, Shin S, Lee S. ECgene: genome-based EST clustering and gene modeling for alternative splicing. Genome Res 2005;15:566-76
   PubMed Web of Science ®Google Scholar
• Kim P, Yoon S, Kim N, et al. ChimerDB 2.0–a knowledgebase for fusion genes updated. Nucleic Acids Res 2010;38:D81-5
   PubMed Web of Science ®Google Scholar
• Forbes SA, Bindal N, Bamford S, et al. COSMIC: Mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 2011;39:D945-50
   PubMed Web of Science ®Google Scholar
• Kim MS, Pinto SM, Getnet D, et al. A draft map of the human proteome. Nature 2014;509:575-81
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Schlegl J, Hahne H, et al. Mass-spectrometry-based draft of the human proteome. Nature 2014;509:582-7
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang J, Wang X, et al. Proteogenomic characterization of human colon and rectal cancer. Nature 2014;513:382-7
   PubMed Web of Science ®Google Scholar
• Liu NQ, Stingl C, Look MP, et al. Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer. J Natl Cancer Inst 2014;106:djt376
   PubMed Web of Science ®Google Scholar
• Bateman NW, Sun M, Bhargava R, et al. Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues. J Proteome Res 2011;10:1323-32
   PubMed Web of Science ®Google Scholar
• Paulo JA, Kadiyala V, Brizard S, et al. A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer. JOP 2013;14:405-14
   PubMedGoogle Scholar
• Liu Y, Chen J, Sethi A, et al. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol Cell Proteomics 2014;13:1753-68
   PubMed Web of Science ®Google Scholar
• Aebersold R, Bader GD, Edwards AM, et al. The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. J Proteome Res 2013;12:23-7
   PubMed Web of Science ®Google Scholar
• Keustermans GC, Hoeks SB, Meerding JM, et al. Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples. Methods 2013;61:10-17
   PubMed Web of Science ®Google Scholar
• David KA, Unger FT, Uhlig P, et al. Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFR-pathway proteins in colorectal cancer tissue. Oncotarget 2014;5:11017-28
   PubMed Web of Science ®Google Scholar
• Gundisch S, Hauck S, Sarioglu H, et al. Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phase. J Proteome Res 2012;11:5748-62
   PubMed Web of Science ®Google Scholar
• Yap TA, Yan L, Patnaik A, et al. First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors. J Clin Oncol 2011;29:4688-95
   PubMed Web of Science ®Google Scholar
• Dunbar SA. Applications of luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta 2006;363:71-82
   PubMed Web of Science ®Google Scholar
• Perkins G, Lievre A, Ramacci C, et al. Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancer. Int J Cancer 2010;127:1321-31
   PubMed Web of Science ®Google Scholar
• Vincent EE, Elder DJ, O’Flaherty L, et al. Glycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation. PLoS One 2014;9:e114725
   PubMed Web of Science ®Google Scholar
• Pierobon M, Belluco C, Liotta L, et al. Reverse Phase Microarrays for Clinical Applications. In: Korf U, editor. Protein microarrays: methods and protocols. Humana Press, Heidelberg; 2011
   Google Scholar
• Silvestri A, Calvert V, Belluco C, et al. Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations. Clin Exp Metastasis 2013;30:309-16
   PubMed Web of Science ®Google Scholar
• Wheeler S, Siwak DR, Chai R, et al. Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma. Clin Cancer Res 2012;18:2278-89
   PubMed Web of Science ®Google Scholar
• Sonntag J, Bender C, Soons Z, et al. Reverse phase protein array based tumor profiling identifies a biomarker signature for risk classification of hormone receptor-positive breast cancer. Translational Proteomics 2014;2:52-9
   Google Scholar
• Ikeda K, Monden T, Kanoh T, et al. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J Histochem Cytochem 1998;46:397-403
   PubMed Web of Science ®Google Scholar
• Chu WS, Liang Q, Liu J, et al. A nondestructive molecule extraction method allowing morphological and molecular analyses using a single tissue section. Lab Invest 2005;85:1416-28
   PubMed Web of Science ®Google Scholar
• Shi SR, Liu C, Balgley BM, et al. Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem 2006;54:739-43
   PubMed Web of Science ®Google Scholar
• Becker KF, Schott C, Metzger V, et al. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol 2007;211:370-8
   PubMed Web of Science ®Google Scholar
• Chung JY, Lee SJ, Kris Y, et al. A well-based reverse-phase protein array applicable to extracts from formalin-fixed paraffin-embedded tissue. Proteomics Clin Appl 2008;2:1539-47
   PubMed Web of Science ®Google Scholar
• Nirmalan NJ, Harnden P, Selby PJ, et al. Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. J Pathol 2009;217:497-506
   PubMed Web of Science ®Google Scholar
• Addis MF, Tanca A, Pagnozzi D, et al. Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics 2009;9:3815-23
   PubMed Web of Science ®Google Scholar
• Berg D, Hipp S, Malinowsky K, et al. Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues. Eur J Cancer 2010;46:47-55
   PubMed Web of Science ®Google Scholar
• Schuster C, Malinowsky K, Liebmann S, et al. Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissues. Histopathology 2012;60:37-50
   PubMed Web of Science ®Google Scholar
• Tibes R, Qiu Y, Lu Y, et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther 2006;5:2512-21
   PubMed Web of Science ®Google Scholar
• Boellner S, Becker K. Reverse Phase Protein Arrays - quantitative assessment of multiple biomarkers in biopsies for clinical use. Microarrays 2015;4:98-114
   Google Scholar
• MD Anderson Cancer Center. Available from: www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/functional-proteomics-rppa-core/antibody-lists-protocols/functional-proteomics-reverse-phase-protein-array-core-facility-antibody-lists-and-protocols.html [Last accessed 19 march 2015]
   Google Scholar
• Malinowsky K, Wolff C, Ergin B, et al. Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays. J Cell Physiol 2010;225:364-70
   PubMed Web of Science ®Google Scholar
• Wilson B, Liotta LA, Petricoin EF. Monitoring proteins and protein networks using reverse phase protein arrays. Dis Markers 2010;28:225-32
   PubMed Web of Science ®Google Scholar
• Voshol H, Ehrat M, Traenkle J, et al. Antibody-based proteomics. Febs J 2009;276:6871-9
   PubMed Web of Science ®Google Scholar
• Akbani R, Becker KF, Carragher N, et al. Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society. Mol Cell Proteomics 2014;13:1625-43
   PubMed Web of Science ®Google Scholar
• Korf U, Lobke C, Sahin O, et al. Reverse-phase protein arrays for application-orientated cancer research. Proteomics Clin Appl 2009;3:1140-50
   PubMed Web of Science ®Google Scholar
• Calvert V, Tang Y, Boveia V, et al. Development of multiplexed protein profiling and detection using near infrared detection of reverse-phase protein microarrays. Clin. Proteomics J 2004;81-9
   Google Scholar
• Mannsperger HA, Gade S, Henjes F, et al. RPPanalyzer: Analysis of reverse-phase protein array data. Bioinformatics 2010;26:2202-3
   PubMed Web of Science ®Google Scholar
• Chiechi A, Mueller C, Boehm KM, et al. Improved data normalization methods for reverse phase protein microarray analysis of complex biological samples. Biotechniques 2012;0:1-7
   PubMedGoogle Scholar
• Rapkiewicz A, Espina V, Zujewski JA, et al. The needle in the haystack: Application of breast fine-needle aspirate samples to quantitative protein microarray technology. Cancer Cytopathol 2007;111:173-84
   PubMed Web of Science ®Google Scholar
• Wulfkuhle JD, Berg D, Wolff C, et al. Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clin Cancer Res 2012;18:6426-35
   PubMed Web of Science ®Google Scholar
• Malinowsky K, Nitsche U, Janssen KP, et al. Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer. Br J Cancer 2014;110:2081-9
   PubMed Web of Science ®Google Scholar
• Wolff C, Malinowsky K, Berg D, et al. Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysis. J Pathol 2011;223:54-63
   PubMed Web of Science ®Google Scholar
• Jameson GS, Petricoin EF, Sachdev J, et al. A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer. Breast Cancer Res Treat 2014;147:579-88
   PubMed Web of Science ®Google Scholar
• Method of the Year 2011. Nat methods 2012;9:1
   PubMed Web of Science ®Google Scholar
• Doerr A. Mass spectrometry-based targeted proteomics. Nat methods 2013;10:23
   PubMed Web of Science ®Google Scholar
• Gillette MA, Carr SA. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat methods 2013;10:28-34
   PubMed Web of Science ®Google Scholar
• Nuciforo P, Radosevic-Robin N, Ng T, et al. Quantification of HER family receptors in breast cancer. Breast Cancer Res 2015;17:53
   PubMed Web of Science ®Google Scholar
• Hembrough T, Thyparambil S, Liao WL, et al. Application of selected reaction monitoring for multiplex quantification of clinically validated biomarkers in formalin-fixed, paraffin-embedded tumor tissue. J Mol Diagn 2013;15:454-65
   PubMed Web of Science ®Google Scholar
• Hembrough T, Thyparambil S, Liao WL, et al. Selected reaction monitoring (SRM) analysis of epidermal growth factor receptor (EGFR) in formalin fixed tumor tissue. Clin Proteomics 2012;9:5
   PubMedGoogle Scholar
• Welinder C, Jonsson G, Ingvar C, et al. Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification. J Proteome Res 2014;13:1315-26
   PubMed Web of Science ®Google Scholar
• Gessel MM, Norris JL, Caprioli RM. MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery. J Proteomics 2014;107:71-82
   PubMed Web of Science ®Google Scholar
• Aichler M, Walch A. MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice. Lab Invest 2015;95(4):422-31
   PubMed Web of Science ®Google Scholar
• van Remoortere A, van Zeijl RJ, van den Oever N, et al. MALDI imaging and profiling MS of higher mass proteins from tissue. J Am Soc Mass Spectrom 2010;21:1922-9
   PubMed Web of Science ®Google Scholar
• Balluff B, Rauser S, Meding S, et al. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. Am J Pathol 2011;179:2720-9
   PubMed Web of Science ®Google Scholar
• Bauer JA, Chakravarthy AB, Rosenbluth JM, et al. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res 2010;16:681-90
   PubMed Web of Science ®Google Scholar
• Hardesty WM, Kelley MC, Mi D, et al. Protein signatures for survival and recurrence in metastatic melanoma. J Proteomics 2011;74:1002-14
   PubMed Web of Science ®Google Scholar
• Nipp M, Elsner M, Balluff B, et al. S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging. J Mol Med (Berl) 2012;90:163-74
   PubMed Web of Science ®Google Scholar
• Reyzer ML, Caldwell RL, Dugger TC, et al. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 2004;64:9093-100
   PubMed Web of Science ®Google Scholar
• Quagliata L, Schlageter M, Quintavalle C, et al. Identification of new players in hepatocarcinogenesis: limits and opportunities of using tissue microarray. Microarrays 2014;3:91-102
   Google Scholar
• Meyer S, Fuchs TJ, Bosserhoff AK, et al. A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One 2012;7:e38222
   PubMed Web of Science ®Google Scholar
• Hu L, Sham JS, Xie D, et al. Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma. Cancer Lett 2007;252:36-42
   PubMed Web of Science ®Google Scholar
• Bae JS, Choi HN, Noh SJ, et al. Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma. Oncol Lett 2012;4:213-20
   PubMed Web of Science ®Google Scholar
• Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat medicine 2002;8:1323-7
   PubMed Web of Science ®Google Scholar
• Nicholson AD, Guo X, Sullivan CA, et al. Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival. J Am Coll Surg 2014;219:977-87
   PubMed Web of Science ®Google Scholar
• Argenta PA, Um I, Kay C, et al. Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer. Gynecol Oncol 2013;131:368-73
   PubMed Web of Science ®Google Scholar
• Gajadhar AS, Johnson H, Slebos RJ, et al. Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity. Cancer res 2015;75:1495-503
   PubMed Web of Science ®Google Scholar
• Mertins P, Yang F, Liu T, et al. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 2014;13:1690-704
   PubMed Web of Science ®Google Scholar
• Lehmann U, Kreipe H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 2001;25:409-18
   PubMed Web of Science ®Google Scholar
• Bosetti C, McLaughlin JK, Tarone RE, et al. Formaldehyde and cancer risk: a quantitative review of cohort studies through. 2006;Ann Oncol 2008;19:29-43
   Web of Science ®Google Scholar
• Nielsen GD, Wolkoff P. Cancer effects of formaldehyde: a proposal for an indoor air guideline value. Arch Toxicol 2010;84:423-46
   PubMed Web of Science ®Google Scholar
• Groelz D, Sobin L, Branton P, et al. Non-formalin fixative versus formalin-fixed tissue: a comparison of histology and RNA quality. Exp Mol Pathol 2013;94:188-94
   PubMed Web of Science ®Google Scholar
• Gundisch S, Schott C, Wolff C, et al. The PAXgene((R)) tissue system preserves phosphoproteins in human tissue specimens and enables comprehensive protein biomarker research. PLoS One 2013;8:e60638
   PubMed Web of Science ®Google Scholar
• Gündisch S, Slotta-Huspenina J, Verderio P, et al. Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial. Virchows Arch 2014;465(5):509-19
   PubMed Web of Science ®Google Scholar
• Ergin B, Meding S, Langer R, et al. Proteomic analysis of PAXgene-fixed tissues. J Proteome Res 2010;9:5188-96
   PubMed Web of Science ®Google Scholar
• Brunelli M, Manfrin E, Martignoni G, et al. Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria. Am J Clin Pathol 2009;131:678-82
   PubMed Web of Science ®Google Scholar
• Pinhel IF, Macneill FA, Hills MJ, et al. Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Am J Clin Pathol 2010;12:R76
   Google Scholar
• Bai Y, Tolles J, Cheng H, et al. Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables. Lab Invest 2011;91:1253-61
   PubMed Web of Science ®Google Scholar
• Li S, Yang X, Zhang Y, et al. Assessment accuracy of core needle biopsy for hormone receptors in breast cancer: a meta-analysis. Breast Cancer Res Treat 2012;135:325-34
   PubMed Web of Science ®Google Scholar
• Meric-Bernstam F, Akcakanat A, Chen H, et al. Influence of biospecimen variables on proteomic biomarkers in breast cancer. Clin can res 2014;20:3870-83
   PubMed Web of Science ®Google Scholar
• Berg D, Langer R, Tran K, et al. Protein microarray-based comparison of HER2, estrogen receptor, and progesterone receptor status in core biopsies and surgial specimens from FFPE breast cancer tissues. Appl Immunhistochem Mol Morphol 2010;19:300-5
   Google Scholar
• Lee AH, Key HP, Bell JA, et al. Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast. Histopathology 2012;60:880-4
   PubMed Web of Science ®Google Scholar
• Grote T, Siwak DR, Fritsche HA, et al. Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer. Proteomics 2008;8:3051-60
   PubMed Web of Science ®Google Scholar
• Syafrizayanti Betzen C, Hoheisel JD, et al. Methods for analyzing and quantifying protein-protein interaction. Expert Rev Proteomics 2014;11:107-20
   PubMed Web of Science ®Google Scholar
• Poste G. Bring on the biomarkers. Nature 2011;469:156-7
   PubMed Web of Science ®Google Scholar
• Kelly RJ, Rajan A, Force J, et al. Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib. Clin can res 2011;17:1190-9
   PubMed Web of Science ®Google Scholar
• Kim YW, Bae SM, Kim IW, et al. Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer. Oncol Rep 2012;28:585-91
   PubMed Web of Science ®Google Scholar
• Irwin ME, Nelson LD, Santiago-O’Farrill JM, et al. Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia. PLoS One 2013;8:e70608
   PubMed Web of Science ®Google Scholar
• Ma D, Baruch D, Shu Y, et al. Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology. BMC Biotechnol 2012;12:88
   PubMed Web of Science ®Google Scholar
• Marx V. Targeted proteomics. Nat methods 2013;10:19-22
   PubMed Web of Science ®Google Scholar
• Picotti P, Bodenmiller B, Aebersold R. Proteomics meets the scientific method. Nat methods 2013;10:24-7
   PubMed Web of Science ®Google Scholar
• Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat methods 2012;9:555-66
   PubMed Web of Science ®Google Scholar